Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy

Number of the records: 1

Title	Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy
Author	Slezáková Darina
Co-authors	Kadlic Pavol
	Jezberová Michaela
	Boleková Veronika
	Valkovič Peter 1976- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV ^SCOPUS ^ORCID
	Minár Michal

Source document	Neurologia i Neurochirurgia Polska. Vol. 57, no. 3 (2023), p. 282-288
Language	eng - English
Country	PL - Poland
Document kind	rozpis článkov z periodík (rbx)
Citations	MAIESE, K. Cognitive Impairment in Multiple Sclerosis. In BIOENGINEERING-BASEL. JUL 2023, vol. 10, no. 7, art. no. 871.
	MAIESE, Kenneth. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk. In Frontiers in Immunology, 2023-01-01, 14, Dostupné na: https://doi.org/10.3389/fimmu.2023.1273570.
	MAIESE, Kenneth. Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK. In Cells, 2023-11-01, 12, 22, Dostupné na: https://doi.org/10.3390/cells12222595.
Category	ADMA - Scientific papers in foreign impacted journals registered in Web of Sciences or Scopus
Category of document (from 2022)	V3 - Vedecký výstup publikačnej činnosti z časopisu
Type of document	článok
Year	2023
Registered in	WOS
Registered in	SCOPUS
DOI	10.5603/PJNNS.a2023.0031

article

	File name	Access	Size	Downloaded	Type	License
	Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy.pdf	available	297.1 KB	0	Publisher's version

rok	CC	IF	IF Q (best)	JCR Av Jour IF Perc	SJR	SJR Q (best)	CiteScore
	N

rok vydania	rok metriky	IF	IF Q (best)	SJR	SJR Q (best)
2023	2022	2.9	Q3	0.438	Q2

Number of the records: 1